Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
xSRBVyFyLHW5wsUT